It would be a mistake to create even a limited Medicare drug benefit that repeats the mistakes of the past.

Reforms that go beyond prescription drugs are needed if the program is to survive the financial pressures created by the baby boomers, who will double Medicare enrollment by 2030.

From rejection to replacement, states should be leaders in the transformation of prosperity, safety and freedom.

Under President Obama’s health care plan, the United States Preventive Services Task Force now wields great power to decide which health services (like mammograms) doctors should provide, yet it has few checks on its sweeping authority.

Are differences in treatment due to deliberate discrimination or other (less invidious) factors?

Congress should revisit the Medicare prescription drug program and insist on significant market-based reforms, not merely an ever-expanding array of benefits.